Category: Posters

2008

  • Iannazzo S, Giuliani G, Zaniolo O, Sacchi V, Pradelli L. New Strategies in the Treatment of Rheumatoid Arthritis Patients in Italy: a Budget Impact Analysis. ISPOR 11th Annual European Congress, Athens, Greece, 8-11 November, 2008
  • Pradelli L, Iannazzo S, Zaniolo O. Cost/Utility Analysis (CUA) of Valsartan for the Treatment of Congestive Heart Failure (CHF) in Italy. ISPOR 11th Annual European Congress, Athens, Greece, 8-11 November, 2008
  • Pradelli L, Iannazzo S. Pharmacoeconomic Evaluation of Solifenacin in the Treatment of Overactive Bladder Syndrome in Italy. ISPOR 11th Annual European Congress, Athens, Greece, 8-11 November, 2008 (PDF)
  • Zaniolo O, Iannazzo S, Bamfi F. Rosiglitazone in the Treatment of Patients With Type 2 Diabetes: Implementation of Budget Impact Analysis Software. SMDM European Congress, 2-4 June, 2008, Engelberg, Switzerland.
  • Iannazzo S, Pradelli L. A Probabilistic Bayesian Markov Model in WinBUGS for the Economic Evaluation of the Treatment With Orlistat of Italian Obese Patients. SMDM European Congress, Engelberg, Switzerland, 2-4 June, 2008
  • Iannazzo S, Pradelli L. Cost Effectiveness of the Cardiovascular Prevention With Ramipril and/or Statins in High Risk Population in Italy. SMDM European Congress, Engelberg, Switzerland, 2-4 June, 2008

2007

  • Eandi M, Zaniolo O, Pradelli L, Iannazzo S. Cost-Effectiveness Analysis and Cost-Utility Analysis of Anti-TNF-α Drugs in Psoriatic Arthritis. ISPOR 10th Annual European Congress, Dublin, Ireland, 20-23 October, 2007 (PDF)
  • Eandi M, Giotta N, Biamino E, Pradelli L, Iannazzo S. Cost-Minimization Analyis of Darbepoetin-α Versus Epoetin-β in Dialysed Patients: a Long-Term Retrospective Monocentric Italian Study. ISPOR 10th Annual European Congress, Dublin, Ireland, 20-23 October, 2007 (PDF)
  • Zaniolo O, Iannazzo S, Bamfi F. Rosiglitazone in the Treatment of Patients With Type 2 Diabetes: Implementation of Budget Impact Analysis Software. ISPOR 10th Annual European Congress, 20-23 October, 2007, Dublin, Ireland.
  • Iannazzo S, Pradelli L. A Probabilistic Bayesian Markov Model in WinBUGS for the Economic Evaluation of the Treatment With Orlistat of Italian Obese Patients. ISPOR 10th Annual European Congress, Dublin, Ireland, 20-23 October, 2007 (PDF)
  • Iannazzo S, Pradelli L. Cost Effectiveness of the Cardiovascular Prevention With Ramipril and/or Statins in High Risk Population in Italy. ISPOR 10th Annual European Congress, Dublin, Ireland, 20-23 October, 2007

2006

  • Eandi M, Iannazzo S, Pradelli L, Patel K, Giuliani G. Cost-Effectiveness of Peginterferon α-2a (40KD) for the Treatment of Chronic Hepatitis B in Italy. ISPOR 9th Annual European Congress, Copenhagen, Denmark, 28-31 October, 2006
  • Pradelli L, Marchettini P, Iannazzo S. Pregabalin vs Gabapentin in the Treatment of Neuropathic Pain in Italy: a Cost-Effectiveness Analysis. ISPOR 9th Annual European Congress, Copenhagen, Denmark, 28-31 October, 2006
  • Eandi M, Iannazzo S, Pradelli L. Prevention With Picotamide and Aspirin in Patients With Type 2 Diabetes Mellitus and Peripheral Arterial Disease: a Pharmacoeconomic Evaluation. ISPOR 9th Annual European Congress, Copenhagen, Denmark, 28-31 October, 2006

2005

  • Eandi M, Dal Negro RW, Pradelli L, Iannazzo S. Inhaled Corticosteroids and Bronchodilators for Severe and Very Severe COPD Patients: Cost-Effectiveness and Health Care Budget Impact in Italy. ISPOR 8th Annual European Congress, Florence, Italy, 6-8 November, 2005
  • Zaniolo O, Pradelli L, Eandi M. Cost-Effectiveness of Preventing of Recurrent Upper Respiratory Tract Infections With non-Specific Immunostimulating Bacterial Extract. ISPOR 8th Annual European Congress, Florence, Italy, 6-8 November, 2005